BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30877174)

  • 1. Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer
    Gallezot JD; Nabulsi N; Henry S; Pracitto R; Planeta B; Ropchan J; Lin SF; Labaree D; Kapinos M; Shirali A; Lara-Jaime T; Gao H; Matuskey D; Walzer M; Marek GJ; Bellaire S; Yuan N; Carson RE; Huang Y
    J Nucl Med; 2019 Aug; 60(8):1140-1146. PubMed ID: 30877174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First in-human PET study and kinetic evaluation of [
    Bhatt S; Nabulsi NB; Li S; Cai Z; Matuskey D; Bini J; Najafzadeh S; Kapinos M; Ropchan JR; Carson RE; Cosgrove KP; Huang Y; Hillmer AT
    J Cereb Blood Flow Metab; 2020 Apr; 40(4):695-704. PubMed ID: 30895878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel
    Baum E; Zhang W; Li S; Cai Z; Holden D; Huang Y
    ACS Chem Neurosci; 2019 May; 10(5):2450-2458. PubMed ID: 30689943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body Mass Index and Age Effects on Brain 11β-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study.
    Bini J; Bhatt S; Hillmer AT; Gallezot JD; Nabulsi N; Pracitto R; Labaree D; Kapinos M; Ropchan J; Matuskey D; Sherwin RS; Jastreboff AM; Carson RE; Cosgrove K; Huang Y
    Mol Imaging Biol; 2020 Aug; 22(4):1124-1131. PubMed ID: 32133575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging brain cortisol regulation in PTSD with a target for 11β-hydroxysteroid dehydrogenase type 1.
    Bhatt S; Hillmer AT; Rusowicz A; Nabulsi N; Matuskey D; Angarita GA; Najafzadeh S; Kapinos M; Southwick SM; Krystal JH; Carson RE; Huang Y; Cosgrove KP
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34651587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging a putative marker of brain cortisol regulation in alcohol use disorder.
    Verplaetse TL; Hillmer AT; Bhatt S; Rusowicz A; Li S; Nabulsi N; Matuskey D; Huang Y; McKee SA; Cosgrove KP
    Neurobiol Stress; 2024 Mar; 29():100609. PubMed ID: 38304303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
    Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
    Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effects of ASP3662, a novel 11β-hydroxysteroid dehydrogenase 1 inhibitor, in rat models of neuropathic and dysfunctional pain.
    Kiso T; Sekizawa T; Uchino H; Tsukamoto M; Kakimoto S
    Br J Pharmacol; 2018 Oct; 175(19):3784-3796. PubMed ID: 30006998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
    Villemagne VL; Doré V; Chong L; Kassiou M; Mulligan R; Feizpour A; Taylor J; Roesner M; Miller T; Rowe CC
    J Alzheimers Dis; 2024; 97(3):1463-1475. PubMed ID: 38250767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
    Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-Human Assessment of
    Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
    J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
    J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
    Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Search for a Subtype-Selective PET Imaging Agent for the GABA
    Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y
    Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.